Cancer of the vulva in Burkina Faso: a hospital-based case series

[1]  N. Hacker,et al.  Corrigendum to “Cancer of the vulva” [Int J Gynecol Obstet 131 Suppl 2(2015) S76–83] , 2016 .

[2]  N. Hacker,et al.  Cancer of the vulva , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[3]  J. Cuzick,et al.  A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women , 2015 .

[4]  S. Klug,et al.  Incidence Patterns and Temporal Trends of Invasive Nonmelanotic Vulvar Tumors in Germany 1999-2011. A Population-Based Cancer Registry Analysis , 2015, PloS one.

[5]  J. Cuzick,et al.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. , 2015, The New England journal of medicine.

[6]  C. Kovarik,et al.  Oncogenic viruses associated with vulva cancer in HIV-1 patients in Botswana , 2014, Infectious Agents and Cancer.

[7]  Fatimazehra Fdili Alaoui,et al.  Un néo de la vulve chez une patiente VIH séropositive: à propos d'un cas historique , 2014, The Pan African Medical Journal.

[8]  Z. Sando,et al.  Profil des cancers gynécologiques et mammaires à Yaoundé - Cameroun , 2014, The Pan African Medical Journal.

[9]  C. Lacey,et al.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa. , 2013, Vaccine.

[10]  L. Kiemeney,et al.  Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. , 2013, European journal of cancer.

[11]  C. Bisseye,et al.  Prevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso) , 2013, Mediterranean journal of hematology and infectious diseases.

[12]  T. Kebdani,et al.  Cancers primitifs invasifs de la vulve: expérience de l’Institut National d’Oncologie de Rabat , 2013 .

[13]  F. Cainelli,et al.  Malignant tumours of the genital tract among Batswana women. , 2012, Ghana medical journal.

[14]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.

[15]  J. Hendriks,et al.  Risk factors for short- and long-term complications after groin surgery in vulvar cancer , 2011, British Journal of Cancer.

[16]  S. Kjaer,et al.  In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007-a nationwide population-based study. , 2011, Gynecologic oncology.

[17]  C. Desimone,et al.  Selective Inguinal Lymphadenectomy in the Treatment of Invasive Squamous Cell Carcinoma of the Vulva , 2011, International journal of surgical oncology.

[18]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[19]  MD PhD Ahizechukwu Eke,et al.  Management options for vulvar carcinoma in a low resource setting , 2010, World journal of surgical oncology.

[20]  T. Wu,et al.  Therapeutic HPV DNA vaccines , 2010, Immunologic research.

[21]  K. Nkyekyer.  Pattern of gynaecological cancers in Ghana. , 2009, East African medical journal.

[22]  E. Trimble,et al.  Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. , 2008, Gynecologic oncology.

[23]  P. Carli,et al.  Vulvar carcinoma associated with lichen sclerosus. Experience at the Florence, Italy, Vulvar Clinic. , 2003, The Journal of reproductive medicine.

[24]  A. Korn,et al.  Vulvar intraepithelial neoplasia in women with HIV. , 1998, AIDS patient care and STDs.

[25]  H. Sancho-Garnier.  Chapitre 4 – Épidémiologie des cancers gynécologiques : utérus, ovaire, vulve et vagin , 2013 .

[26]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[27]  Bibi Mohamed,et al.  Les facteurs pronostiques du carcinome epidermoïde de la vulve : A propos de 35 cas , 2005 .

[28]  J. Lansac.  Gynécologie pour le praticien , 1999 .

[29]  A. Kunlin.  Cancer de la vulve , 1983 .